Drugmaker Norvo Nordisk limits obesity drug Wegovy in U.S.

Danish drugmaker Novo Nordisk said it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.